As the pharmaceutical industry faces increasing pressure to be more patient-centric, ensuring sufficient focus on the ultimate end consumer for medicines is starting to permeate into every…
The controversy over the pricing of Gilead’s Sovaldi for Hepatitis C is a textbook example of price discrimination in action. I hope that my quick review of some of…
The Buzz About Specialty PharmacyIf you’ve been hearing a lot of buzz about “specialty drugs” and “specialty pharmacies” you might be wondering what exactly is being alluded to…
So far this year there has been a lot in the news about M&A activity within the pharmaceutical industry, and lately the coverage seems to be about…
Last week's news about Pfizer's $17 billion deal to acquire Hospira, a leading generic injectibles and biosimilars company, shows some of the tectonic shifts taking place in…
Just give me the cheapest oneMakers and buyers of new Hepatitis C drugs have been slugging it out in public lately. What’s going on and what are…
The Food and Drug Administration gets a lot of grief. Some think the FDA is too restrictive, keeping useful drugs and devices off the market and thus harming patients.…
The U.S. pharmaceutical industry has taken some pretty severe hits over the past decade, and recent news suggests that it isn't over yet. The U.S. pharmaceutical industry…
_9.jpg)
Let’s start with a few realities: Let’s start with a few realities:More than half of all physicians in practice in the US graduated from medical school at…
Anyone who has ever had the displeasure of heading to the pharmacy to fill a prescription sans insurance knows that the cost of prescription drugs can be…
![Understanding Alzheimer’s Disease: What’s Next? [Infographic]](https://www.healthworkscollective.com/wp-content/uploads/2017/11/Alzheimer’s-Disease-300x250.jpeg)
